Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Synageva BioPharma Corp GEVA

NDAQ:GEVA - Post Discussion

Synageva BioPharma Corp > your market, your trials, your support and your credibility!
View:
Post by drjekyl on Jun 26, 2014 9:20am

your market, your trials, your support and your credibility!

guys, i personally think, after listening to the 35th annual gs global healthcare conference audio presentation, that you may have significantly greater obstacles to overcome than what we all think. the fact that your ceo sold $40mm worth of stock leads me to belive that i may be right.
 
in my ever so humble opinion, there's only one way for you to take on the market and potential competitors head on at this time. go ahead, make my day and ask me how!
 
these are my thoughts, not yours, i'm...............
#toindwbmahbnDRJ! aka Mr Wonderful
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities